264 related articles for article (PubMed ID: 22802349)
41. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues.
Cheng AG; Kim HK; Burts ML; Krausz T; Schneewind O; Missiakas DM
FASEB J; 2009 Oct; 23(10):3393-404. PubMed ID: 19525403
[TBL] [Abstract][Full Text] [Related]
42. The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients.
Barretti P; Montelli AC; Batalha JE; Caramori JC; Cunha Mde L
BMC Infect Dis; 2009 Dec; 9():212. PubMed ID: 20028509
[TBL] [Abstract][Full Text] [Related]
43. Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin.
Scherr TD; Hanke ML; Huang O; James DB; Horswill AR; Bayles KW; Fey PD; Torres VJ; Kielian T
mBio; 2015 Aug; 6(4):. PubMed ID: 26307164
[TBL] [Abstract][Full Text] [Related]
44. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity.
Cheng AG; McAdow M; Kim HK; Bae T; Missiakas DM; Schneewind O
PLoS Pathog; 2010 Aug; 6(8):e1001036. PubMed ID: 20700445
[TBL] [Abstract][Full Text] [Related]
45. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
Fattom AI; Sarwar J; Ortiz A; Naso R
Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375
[TBL] [Abstract][Full Text] [Related]
46. α-Hemolysin suppresses osteogenesis by inducing lipid rafts accumulation in bone marrow stromal cells.
Liu G; Cheng C; Guan X; Ji Z; Su J; Zhang X; Yu B
Food Chem Toxicol; 2020 Nov; 145():111689. PubMed ID: 32810588
[TBL] [Abstract][Full Text] [Related]
47. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.
Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D
J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200
[TBL] [Abstract][Full Text] [Related]
48. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
Delfani S; Mohabati Mobarez A; Imani Fooladi AA; Amani J; Emaneini M
Med Microbiol Immunol; 2016 Feb; 205(1):47-55. PubMed ID: 26155981
[TBL] [Abstract][Full Text] [Related]
49. In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
Oscherwitz J; Muñoz-Planillo R; Yu F; Núñez G; Cease KB
Mol Immunol; 2014 Jul; 60(1):62-71. PubMed ID: 24769493
[TBL] [Abstract][Full Text] [Related]
50. IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge.
Kim HK; DeDent A; Cheng AG; McAdow M; Bagnoli F; Missiakas DM; Schneewind O
Vaccine; 2010 Aug; 28(38):6382-92. PubMed ID: 20226248
[TBL] [Abstract][Full Text] [Related]
51. Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice.
Kim HK; Emolo C; DeDent AC; Falugi F; Missiakas DM; Schneewind O
Infect Immun; 2012 Oct; 80(10):3460-70. PubMed ID: 22825452
[TBL] [Abstract][Full Text] [Related]
52. α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis.
Surewaard BGJ; Thanabalasuriar A; Zeng Z; Tkaczyk C; Cohen TS; Bardoel BW; Jorch SK; Deppermann C; Bubeck Wardenburg J; Davis RP; Jenne CN; Stover KC; Sellman BR; Kubes P
Cell Host Microbe; 2018 Aug; 24(2):271-284.e3. PubMed ID: 30033122
[TBL] [Abstract][Full Text] [Related]
53. Pulmonary infection of cystic fibrosis mice with Staphylococcus aureus requires expression of α-toxin.
Keitsch S; Riethmüller J; Soddemann M; Sehl C; Wilker B; Edwards MJ; Caldwell CC; Fraunholz M; Gulbins E; Becker KA
Biol Chem; 2018 Sep; 399(10):1203-1213. PubMed ID: 29613852
[TBL] [Abstract][Full Text] [Related]
54. Simultaneous lack of catalase and beta-toxin in Staphylococcus aureus leads to increased intracellular survival in macrophages and epithelial cells and to attenuated virulence in murine and ovine models.
Martínez-Pulgarín S; Domínguez-Bernal G; Orden JA; de la Fuente R
Microbiology (Reading); 2009 May; 155(Pt 5):1505-1515. PubMed ID: 19383704
[TBL] [Abstract][Full Text] [Related]
55. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
[TBL] [Abstract][Full Text] [Related]
56. Vaccine protection against Staphylococcus aureus pneumonia.
Bubeck Wardenburg J; Schneewind O
J Exp Med; 2008 Feb; 205(2):287-94. PubMed ID: 18268041
[TBL] [Abstract][Full Text] [Related]
57. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
Uppalapati SR; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
[TBL] [Abstract][Full Text] [Related]
58. Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model.
Kernodle DS; Voladri RK; Menzies BE; Hager CC; Edwards KM
Infect Immun; 1997 Jan; 65(1):179-84. PubMed ID: 8975909
[TBL] [Abstract][Full Text] [Related]
59. Possible virulence factors of Staphylococcus aureus in a mouse septic model.
Tao M; Yamashita H; Watanabe K; Nagatake T
FEMS Immunol Med Microbiol; 1999 Feb; 23(2):135-46. PubMed ID: 10076910
[TBL] [Abstract][Full Text] [Related]
60. α-Hemolysin enhances Staphylococcus aureus internalization and survival within mast cells by modulating the expression of β1 integrin.
Goldmann O; Tuchscherr L; Rohde M; Medina E
Cell Microbiol; 2016 Jun; 18(6):807-19. PubMed ID: 26595647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
